TMCnet News

www.Xtremepicks.Com: Xtremepicks Alerts November 16, 2009 : RFMD, NETL, ALKS and CTXS
[November 17, 2009]

www.Xtremepicks.Com: Xtremepicks Alerts November 16, 2009 : RFMD, NETL, ALKS and CTXS


(M2 PressWIRE Via Acquire Media NewsEdge) Xtremepicks.com Alerts include RF Micro Devices, Inc. (Nasdaq: RFMD), NetLogic Microsystems, Inc. (NASDAQ: NETL), Alkermes, Inc. (NASDAQ: ALKS) and Citrix Systems, Inc. (NASDAQ: CTXS) RF Micro Devices, Inc. (Nasdaq:RFMD) trading at $4.47 on a volume of 3.12M shares In a press release out on November 16, RFMD Repurchases and Retires $197 Million of Convertible Notes Due 2010 GREENSBORO, N.C., Nov 16, 2009 -- RF Micro Devices, Inc. (Nasdaq:RFMD), a global leader in the design and manufacture of high-performance radio frequency components and compound semiconductor technologies, today announced that it has repurchased and retired $197 million aggregate principal amount of its convertible subordinated notes due 2010 (the "Notes"). Using cash on hand, RFMD paid the principal, or face, amount of the Notes along with accrued interest to acquire and retire the Notes prior to maturity. The aggregate principal amount of the 2010 Notes outstanding is now approximately $10.0 million, down from $230.0 million at issue.

About RFMD RF Micro Devices, Inc. (Nasdaq:RFMD) is a global leader in the design and manufacture of high-performance radio frequency components and compound semiconductor technologies. RFMD's products enable worldwide mobility, provide enhanced connectivity and support advanced functionality in the cellular handset, wireless infrastructure, wireless local area network (WLAN), CATV/broadband and aerospace and defense markets. RFMD is recognized for its diverse portfolio of semiconductor technologies and RF systems expertise and is a preferred supplier to the world's leading mobile device, customer premises and communications equipment providers.

NetLogic Microsystems, Inc. (NASDAQ:NETL) trading at $42.59 per share on trading volume of 82,639 shares.


In a press release out on November 16, NetLogic Microsystems Powers LG Electronics' High-Performance Automotive Infotainment Solutions with Ultra Low-Power Alchemy(R) Processors NetLogic Microsystems' Alchemy(R) Processors Deliver the Superior Processing Performance, Robust Media Acceleration and Ultra Low-Power Required for Intelligent Next-Generation Connected Automotive Solutions MOUNTAIN VIEW, Calif., Nov 16, 2009 -- NetLogic Microsystems, Inc. (NASDAQ:NETL), a worldwide leader in high-performance intelligent semiconductor solutions for next-generation Internet networks, today announced that its Au1300(R) Processor, the latest member of its ultra low-power Alchemy(R) processor family, has been selected by LG Electronics for LG's high-performance automotive infotainment solutions. LG's market-leading infotainment solutions include built-in audio/video navigation (AVN) for dashboard and rear-seat entertainment (RSE) systems.

About NetLogic Microsystems NetLogic Microsystems, Inc. (NASDAQ:NETL), is a worldwide leader in high-performance intelligent semiconductor solutions that are powering next-generation Internet networks. NetLogic Microsystems' best-in-class products perform highly differentiated tasks of accelerating complex network traffic to significantly enhance the performance and functionality of advanced 3G/4G mobile wireless infrastructure, data center, enterprise, metro Ethernet, edge and core infrastructure networks. NetLogic Microsystems' market-leading product portfolio includes high-performance multi-core processors, knowledge-based processors, content processors, network search engines, ultra low-power embedded processors and high-speed 10/40/100 Gigabit Ethernet PHY solutions. These products are designed into high-performance systems such as switches, routers, wireless base stations, security appliances, networked storage appliances, service gateways and connected media devices offered by leading original equipment manufacturers (OEMs). NetLogic Microsystems is headquartered in Mountain View, California, and has offices and design centers throughout North America, Asia and Europe. For more information about products offered by NetLogic Microsystems, call +1-650-961-6676 or visit the NetLogic Microsystems Web site athttp://www.netlogicmicro.com.

Alkermes, Inc. (NASDAQ: ALKS) trading at $8.09 on a volume of 589,894 shares In a press release out on November 16, Alkermes Announces Positive Results from Phase 3 Clinical Study of Naltrexone for Extended-Release Injectable Suspension for the Treatment of Opioid Dependence -- Once-Monthly, Non-Addictive Treatment Significantly Reduced Opioid Use in Multicenter, Six-Month Study -- CAMBRIDGE, Mass., Nov 16, 2009 -- -- Company to File for FDA Approval in the First Half of Calendar 2010 -- Alkermes, Inc. (NASDAQ: ALKS) today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002). Based on the positive results of this phase 3 study, Alkermes plans to file a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration (FDA) in the first half of calendar 2010. XR-NTX, marketed by Alkermes as VIVITROL(R), is an opioid antagonist administered once-monthly by intramuscular injection and is approved in the U.S. for the treatment of alcohol dependence. If approved by the FDA for the treatment of opioid dependence, XR-NTX has the potential to be the first and only non-narcotic, non-addictive drug agent available in a once-monthly formulation.

About Alkermes Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL(R) for alcohol dependence and manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.

Citrix Systems, Inc. (NASDAQ: CTXS) trading at $39.41 on a volume of 499,894 shares In a press release out on November 16, Citrix Dazzles End Users with Self-Service Virtual Desktops from Millions of Devices Citrix Dazzle and Receiver Bring Self-Service and Mobility to Virtual Desktop Users; New Releases Support Blackberry and Android Devices SANTA CLARA, Calif., Nov 16, 2009 -- To further accelerate the mainstream adoption of desktop virtualization, Citrix Systems, Inc. (NASDAQ: CTXS) today announced the general availability of Citrix(R) Dazzle(TM) for Windows and Mac, along with new versions of Citrix(R) Receiver(TM) for Windows, Mac, iPhone, BlackBerry and Android. The new releases make virtual desktops far more compelling for end users, enabling unprecedented levels of flexibility, mobility and self service. As the first self-service "storefront" for enterprise applications, Citrix Dazzle gives corporate employees 24x7 self-service access to a broad array of applications, desktops and content, allowing them to choose exactly what they need, when they need it. Citrix Receiver is a lightweight software client that makes accessing virtual desktops and applications on any device as easy as turning on your TV. Together, Dazzle and Receiver work with Citrix(R) XenDesktop(TM), the company's market-leading desktop virtualization solution, to power self-service IT for a wide range of virtual desktops, giving every user in the enterprise instant access to their corporate desktops and applications from whatever device is most convenient at the time.

About Citrix Citrix Systems, Inc. (NASDAQ:CTXS) is a leading provider of virtualization, networking and cloud computing solutions for more than 230,000 organizations worldwide. Its Citrix Delivery Center(TM), Citrix Cloud Center(TM) (C3) and Citrix Online product families radically simplify computing for millions of users, delivering desktops and applications as an on-demand service to any user, in any location on any device. Citrix customers include the world's largest Internet companies, 99 percent of Fortune Global 500 enterprises, and hundreds of thousands of small businesses and prosumers worldwide. Citrix partners with over 10,000 companies worldwide in more than 100 countries. Founded in 1989, annual revenue in 2008 was $1.6 billion.

Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience.

Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at [email protected] Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm ((Comments on this story may be sent to [email protected])) (c) 2009 M2 COMMUNICATIONS

[ Back To TMCnet.com's Homepage ]